Emerald Advisers, LLC G1 Therapeutics, Inc. Transaction History

Emerald Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2019	SELL	$16.51 - $51.33 $8.02 Million - $24.9 Million	-485,954 Closed	0 $0
Q3 2018 Oct 31, 2018	SELL	$43.15 - $67.97 $883,280 - $1.39 Million	-20,470 Reduced 4.04%	485,954 $25.4 Million
Q2 2018 Jul 31, 2018	SELL	$35.06 - $51.17 $6.87 Million - $10 Million	-195,975 Reduced 27.9%	506,424 $22 Million
Q1 2018 Apr 26, 2018	SELL	$19.05 - $41.76 $362,692 - $795,068	-19,039 Reduced 2.64%	702,399 $26 Million
Q4 2017 Feb 05, 2018	SELL	$19.01 - $26.2 $132,974 - $183,269	-6,995 Reduced 0.96%	721,438 $14.3 Million
Q3 2017 Oct 30, 2017	BUY	$12.53 - $27.12 $9.13 Million - $19.8 Million	728,433	728,433 $18.1 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.